In Angola on likely his last overseas trip in office, the president will tour a slavery museum and spotlight a rail corridor ...

Investing.com -- Healthcare stocks in the U.S. and Europe have tumbled since Donald Trump’s election victory on November 5, with concerns rising over the potential policy impact of his cabinet picks, ...

It's uncertain whether the Biden administration proposal to cover obesity drugs in Medicare and Medicaid will survive ...

Even as weight-loss drugs such as Wegovy and Zepbound explode in popularity, many Americans struggle to afford them.

A proposal floated Tuesday by outgoing President Joe Biden to require Medicare and Medicaid to offer coverage for prescriptions of popular but expensive injectable weight loss drugs had the tentative ...

The Biden Administration released plans for a new rule that would require Medicare and Medicaid to cover anti-obesity ...

Discover how Trump’s healthcare picks could reshape U.S. biopharma and drive major changes in the healthcare policy.

While recent advances in medicine have created prescription anti-obesity GLP-1 medications — like Ozempic, Wegovy, and ...

This summary covers recent developments in the health sector, including studies on thyroid medications and asthma drugs, ...

Understanding Medicare basics may be one of the most maddening tasks you'll face when heading into retirement. Figuring out when to enroll in Medicare and which parts of Medicare to elect can be ...

President Joe Biden's plan to authorize Medicare and Medicaid cover anti-obesity medications starting in 2026 would $140 ...